(Q40399356)

English

A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine design

scientific article published on 15 January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 September 2017

A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine design (English)

1 reference

Europe PubMed Central

20 September 2017

1 reference

based on heuristic

inferred from title

vaccine engineering

1 reference

based on heuristic

inferred from title

author name string

Hsin-Wei Chen

1

1 reference

Europe PubMed Central

20 September 2017

Shih-Jen Liu

2

1 reference

Europe PubMed Central

20 September 2017

Hsueh-Hung Liu

3

1 reference

Europe PubMed Central

20 September 2017

Yan Kwok

4

1 reference

Europe PubMed Central

20 September 2017

Chang-Ling Lin

5

1 reference

Europe PubMed Central

20 September 2017

Li-Hsiu Lin

6

1 reference

Europe PubMed Central

20 September 2017

Mei-Yu Chen

7

1 reference

Europe PubMed Central

20 September 2017

Jy-Ping Tsai

8

1 reference

Europe PubMed Central

20 September 2017

Li-Sheng Chang

9

1 reference

Europe PubMed Central

20 September 2017

Fang-Feng Chiu

10

1 reference

Europe PubMed Central

20 September 2017

Li-wei Lai

11

1 reference

Europe PubMed Central

20 September 2017

Wei-Cheng Lian

12

1 reference

Europe PubMed Central

20 September 2017

Chiou-Ying Yang

13

1 reference

Europe PubMed Central

20 September 2017

Shih-Yang Hsieh

14

1 reference

Europe PubMed Central

20 September 2017

Pele Chong

15

1 reference

Europe PubMed Central

20 September 2017

Chih-Hsiang Leng

16

1 reference

Europe PubMed Central

20 September 2017

language of work or name

0 references

publication date

15 January 2009

1 reference

Europe PubMed Central

20 September 2017

1 reference

Europe PubMed Central

20 September 2017

27

1 reference

Europe PubMed Central

20 September 2017

9

1 reference

Europe PubMed Central

20 September 2017

1400-1409

1 reference

Europe PubMed Central

20 September 2017

Spinning molecular immunology into successful immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.043

7 January 2021

Protection of mice against the Lyme disease agent by immunizing with recombinant OspA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.043

7 January 2021

Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.043

7 January 2021

The outer surface protein A (OspA) vaccine against Lyme disease: efficacy in the rhesus monkey.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.043

7 January 2021

Incomplete protection of hamsters vaccinated with unlipidated OspA from Borrelia burgdorferi infection is associated with low levels of antibody to an epitope defined by mAb LA-2

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.043

7 January 2021

A novel mycobacterial antigen relevant to cellular immunity belongs to a family of secreted lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.043

7 January 2021

Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.043

7 January 2021

Induction of direct antimicrobial activity through mammalian toll-like receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.043

7 January 2021

Covalent binding of lipid to protein. Diglyceride and amide-linked fatty acid at the N-terminal end of the murein-lipoprotein of the Escherichia coli outer membrane.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.043

7 January 2021

Lipoprotein synthesis in mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.043

7 January 2021

Production of lipidated meningococcal transferrin binding protein 2 in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.043

7 January 2021

Construction and evaluation of a plasmid vector for the expression of recombinant lipoproteins in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.043

7 January 2021

Bacterial lipid modification of proteins for novel protein engineering applications.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.043

7 January 2021

Expression of truncated and full-length forms of the Lyme disease Borrelia outer surface protein A in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.043

7 January 2021

A recombinant lipoprotein antigen against Lyme disease expressed in E. coli: fermentor operating strategies for improved yield

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.043

7 January 2021

The toxicity of recombinant proteins in Escherichia coli: a comparison of overexpression in BL21(DE3), C41(DE3), and C43(DE3).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.043

7 January 2021

Immunoproteomic identification of the hypothetical protein NMB1468 as a novel lipoprotein ubiquitous in Neisseria meningitidis with vaccine potential

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.043

7 January 2021

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.043

7 January 2021

The structure of signal peptides from bacterial lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.043

7 January 2021

Lipoproteins in bacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.043

7 January 2021

A novel dengue vaccine candidate that induces cross-neutralizing antibodies and memory immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.043

7 January 2021

The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.043

7 January 2021

Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.043

7 January 2021

Discrimination of bacterial lipoproteins by Toll-like receptor 6

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.043

7 January 2021

Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.043

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipopeptides of Borrelia burgdorferi outer surface proteins induce Th1 phenotype development in alphabeta T-cell receptor transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.043

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2008.12.043

1 reference

Europe PubMed Central

20 September 2017

1 reference

Europe PubMed Central

20 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40399356&oldid=2098908826"